Ask the Expert: Advanced Lung Cancer

Ask the Expert with Dana-Farber Cancer Institute’s Dr. Jackman CancerConnect recently partnered with Dana-Farber Cancer Institute to provide you with […]

Lung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference

Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented […]

16th World Conference on Lung Cancer Expected to Highlight Advances in Precision Medicine

Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s […]

Innovative Clinical Trials for Lung Cancer Currently Underway

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current […]

National Lung Cancer Awareness Month on CancerConnect

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs […]

Most Survivors of Lung and Colorectal Cancer Keep Their Jobs

Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published […]

November Is National Lung Cancer Awareness Month

As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information throughout the year.

Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer

Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy alone. The results of this study were published in the Journal of the National Cancer Institute.

Non-Platinum Chemotherapy as Effective for SCLC

Non-Platinum Chemotherapy as Effective for SCLC Chemotherapy regimens that do not contain platinum agents (Platinol and Paraplatin) appear to be just as effective as regimens that do contain platinum agents in the treatment of small cell lung cancer. These results were recently published in the Cochrane Database of Systematic Reviews. Small cell lung cancer (SCLC) accounts for approximately one-quarter of all lung cancers.